• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    InClinica Names BD Manager

    SCHOTT Introduces syriQ BioPure

    Heritage Pharma Makes Leadership Changes

    JLL and Water Street Acquire Triplefin

    WuXi AppTec Opens Laboratory Testing Facility in NJ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Welcomes Illinois Governor

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    ICON, Intel Enter Pharma Analytics Platform Pact

    AMRI Renews NIH Contract

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Unither Pharmaceuticals

    Adaptive Clinical Systems

    IQVIA

    Piramal Pharma Solutions

    Dow Development Laboratories, LLC
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Gilead To Acquire YM BioSciences

    Gains JAK Inhibitor set for Phase III trials

    Related CONTENT
    • YM BioSciences JAK1/2 Inhibitor Gets Orphan Designation
    • Gilead To Acquire Arresto Biosciences
    • Gilead To Acquire Calistoga
    • Sage Bionetworks, AZ Enter Cancer Pact
    • Gilead, MicroDose Enter RSV Pact
    12.12.12
    Gilead Sciences has signed a definitive agreement to acquire YM BioSciences in transaction valued at approximately $510 million in cash. The transaction is expected to close in 1Q13.
     
    YM’s lead drug candidate, CYT387, is an oral selective inhibitor of the Janus kinase (JAK) family, which has been implicated in a number of disorders including myeloproliferative diseases, inflammatory disorders and certain cancers. YM reported positive results from a Phase I/II trial of CYT387 in patients with myelofibrosis. Following the acquisition, Gilead plans to initiate a Phase III trial of CYT387 in myelofibrosis in 1H13.
     
    “This acquisition represents an opportunity to add a complementary clinical program in the area of hematologic cancers to our growing oncology portfolio,” said Norbert W. Bischofberger, Ph.D., Gilead’s executive vice president, R&D and chief scientific officer. “Based on promising Phase II data, we believe CYT387 could provide important clinical benefit for patients with myelofibrosis, including potential improvements with regard to anemia and decreased dependence on blood transfusions. We look forward to advancing CYT387 into a Phase 3 study as quickly as possible and to exploring its potential in other myeloproliferative diseases with significant unmet medical need.”
    Related Searches
    • Phase II
    • Phase I
    • Phase III
    Suggested For You
    Amygdala Acquires Gilead Amygdala Acquires Gilead's Addiction Disorder Candidiate
    Innate Achieves $15M BMS Milestone Innate Achieves $15M BMS Milestone
    Gilead Acquires Phenex FXR Program Gilead Acquires Phenex FXR Program
    ONO, Gilead to Develop BTK Inhibitor ONO, Gilead to Develop BTK Inhibitor
    Merck, GSK In Kidney Cancer Alliance Merck, GSK In Kidney Cancer Alliance
    Stellar, Amaran Enter Manufacturing Pact Stellar, Amaran Enter Manufacturing Pact
    Trials & Filings in Brief: Nov. 27, 2013 Trials & Filings in Brief: Nov. 27, 2013
    Threshold Cancer Treatment Shows Safety Threshold Cancer Treatment Shows Safety
    Tekmira Names Chief Medical Officer Tekmira Names Chief Medical Officer
    Gilead Buys Genentech Clinical Facility Gilead Buys Genentech Clinical Facility
    Gilead, MicroDose Enter RSV Pact Gilead, MicroDose Enter RSV Pact
    Sage Bionetworks, AZ Enter Cancer Pact    Sage Bionetworks, AZ Enter Cancer Pact
    Gilead To Acquire Calistoga Gilead To Acquire Calistoga
    Gilead To Acquire Arresto Biosciences Gilead To Acquire Arresto Biosciences
    YM BioSciences JAK1/2 Inhibitor Gets Orphan Designation YM BioSciences JAK1/2 Inhibitor Gets Orphan Designation

    Related Breaking News

    • Promotions & Moves
      InClinica Names BD Manager

      InClinica Names BD Manager

      Kumar brings 12 years of experience in pharmaceuticals and clinical research
      04.20.18

    • SCHOTT Introduces syriQ BioPure

      SCHOTT Introduces syriQ BioPure

      Enhances iQ platform with new glass syringe for sensitive drugs
      04.20.18

    • Breaking News | Industry News | Promotions & Moves
      Heritage Pharma Makes Leadership Changes

      Heritage Pharma Makes Leadership Changes

      William Marth named president and CEO, North America and Europe; John Denman now president of Heritage Pharmaceuticals Inc.
      04.20.18


    • Breaking News | Industry News
      JLL and Water Street Acquire Triplefin

      JLL and Water Street Acquire Triplefin

      Expand global life sciences commercialization services platform
      04.20.18

    • Breaking News | Facilities | Industry News
      WuXi AppTec Opens Laboratory Testing Facility in NJ

      WuXi AppTec Opens Laboratory Testing Facility in NJ

      Expands site in the U.S. for drug development testing services
      04.20.18

    • CRO News
      ICON, Intel Enter Pharma Analytics Platform Pact

      ICON, Intel Enter Pharma Analytics Platform Pact

      ICON to offer the Intel Pharma Analytics Platform for use in clinical trials
      04.20.18


    • Breaking News | Industry News
      AMRI Renews NIH Contract

      AMRI Renews NIH Contract

      Re-ups 10-year NIH contract to support the Blueprint Neurotherapeutics Network
      04.20.18

    • Bio News | Facilities | Industry News
      Sterling Pharma Invests £6M To Expand Offerings

      Sterling Pharma Invests £6M To Expand Offerings

      For its pilot plant facility to enhance scale-up and small to midscale commercial API manufacturing capabilities
      04.19.18

    • AGC Chemicals to Feature Advanced Intermediates

      Companies fluorinated molecules serve as building blocks for pharmaceutical products
      04.18.18


    • Avema to Showcase Range of Services

      CDMO provides turnkey contract manufacturing and packaging for oral solid and liquid dosage delivery systems
      04.18.18

    • Peter Stein to Deliver FDA Keynote Presentation

      Dr. Stein joined FDA in late 2016 as the deputy director at the OND, CDER
      04.18.18

    • CPhI NA Conference to Focus on Fostering Innovation

      Full schedule features more than 30 sessions
      04.18.18

    • CPhI NA to Feature Second Women in Leadership Forum

      Panel of pharma execs to discuss strategies for diversity and the vital role of women executives in progressive organizations
      04.18.18

    • Second Keynote To Emphasize Digital Medicine Opportunities

      Digital health leader Nik Leist to present second CPhI North America keynote address
      04.18.18

    • The Medical Futurist Dr. Bertalan Mesko to Deliver First Keynote

      Will explore convergence of digital health, communications and patient-led changes
      04.18.18

    Breaking News
    • InClinica Names BD Manager
    • SCHOTT Introduces syriQ BioPure
    • Heritage Pharma Makes Leadership Changes
    • JLL and Water Street Acquire Triplefin
    • WuXi AppTec Opens Laboratory Testing Facility in NJ
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.